1-9 of 9
Seth J. Corey, MD MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutations in the Splicosome Lead to Alternative Splicing of CSF3R in Promoting Myelodysplastic Syndromes

Frances Austin, MD, Hrishikesh M Mehta, PhD, Seth J. Corey, MD MPH, Chonghui Cheng, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3897.
https://doi.org/10.1182/blood.V128.22.3897.3897
Published: 2016
Journal Articles

Genetic Ablation of Sbds in Zebrafish Results in Neutropenia, Diminished Growth, and Reduced Viability, Indicating Its Roles in Embryonic and Post-Embryonic Development

Usua Oyarbide, PhD, Margaret J Kell, Javier Farinas, BS, Rachel Hartig, Jacek Topczewski, PhD, Seth J. Corey, MD MPH
Journal: Blood
Blood (2015) 126 (23): 3607.
https://doi.org/10.1182/blood.V126.23.3607.3607
Published: 2015
Journal Articles

Specific Gtpase Dynamin Isoforms Regulate Megakaryocyte Membrane Remodeling and The Formation Of Multivesicular Bodies and Microparticles

Yolande Chen, MD, Arinola Awomolo, MD, Jorie Aardema, BS, Michael Hession, Francisco Javier Gonzalez, MD, Hilary Christensen, Walter H. Kahr, MD, PhD, Seth J. Corey, MD, MPH
Journal: Blood
Blood (2013) 122 (21): 3529.
https://doi.org/10.1182/blood.V122.21.3529.3529
Published: 2013
Journal Articles

Profound Signaling Abnormalities Due to Cytoplasmic Variants of CSF3R in Patients with Myelodysplastic/Myeloproliferative Syndromes Associated with CSF3R Mutations or Mutations of Splicing Factor U2AF1

Hrishikesh Mehta, PhD, Hideki Maskishima, Muneyoshji Futami, MD, PhD, Wei-Ming Kao, Bartlomiej P Przychodzen, Chonghui Cheng, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD, Seth J. Corey, MD, MPH
Journal: Blood
Blood (2012) 120 (21): 3792.
https://doi.org/10.1182/blood.V120.21.3792.3792
Published: 2012
Journal Articles

Bioimaging of Vascular Microenvironment Reveals Presence of Fli1a, Not VEGFR2, in Acute Lymphoblastic Leukemia Model in Syngeneic Zebrafish

Sergei Revskoy, MD, PhD, Igor Mizgirev, PhD, Seth J. Corey, MD, MPH
Journal: Blood
Blood (2011) 118 (21): 2551.
https://doi.org/10.1182/blood.V118.21.2551.2551
Published: 2011
Journal Articles

SHIP1 Is a Novel Tumor Suppressor in Late-Stage Myelodysplastic Syndromes and Is Silenced by Mir-210 and Mir-155.

Daniel W. Lee, MD, Carlos E. Bueso-Ramos, MD, Martin Carroll, MD, Zak Whichard, BA, Yanming Feng, PhD, Peter Stein, Samuel A. Jensen, BS, Steven M. Kornblau, MD, Seth J. Corey, MD, MPH
Journal: Blood
Blood (2009) 114 (22): 3824.
https://doi.org/10.1182/blood.V114.22.3824.3824
Published: 2009
Journal Articles

Abnormal PI 3-Kinase Activity Due to Increased Lyn with Decreased PTEN and Absent SHIP in Bone Marrow Cells from Patients with Myelodysplastic Syndromes.

Daniel W. Lee, MD, Quan-Sheng Zhu, MD, PhD, Sonali Rudra, BS, Elizabeth J. Shpall, MD, Steven Kornblau, MD, Seth J. Corey, MD, MPH
Journal: Blood
Blood (2005) 106 (11): 3446.
https://doi.org/10.1182/blood.V106.11.3446.3446
Published: 2005
Journal Articles

The Dual SRC/ABL Kinase Inhibitor BMS-354825 Potently Inhibits the Growth of Myeloid Leukemic Cells Characterized by FLT3-ITD Expression, GM-CSF Dependency, or G-CSF Responsiveness Via an ABL-Independent Mechanism.

Jukka Kanerva, MD, PhD, Ogonna Nwawka, BS, Kevin Hwang, Francis Y. Lee, PhD, Seth J. Corey, MD, MPH
Journal: Blood
Blood (2004) 104 (11): 4480.
https://doi.org/10.1182/blood.V104.11.4480.4480
Published: 2004
Journal Articles

Disturbed Regulation and Activity of PI 3-Kinase Activity Due to Enhanced Lyn Kinase but Decreased Ship-1 and Gab2 Levels in Patients with Myelodysplastic Syndrome.

Daniel W. Lee, MD, Quan-Sheng Zhu, MD, PhD, Gus Zamora, BS, Ogonna Nwawka, BS, Elizabeth J. Shpall, MD, Steven K. Kornblau, MD, Seth J. Corey, MD, MPH
Journal: Blood
Blood (2004) 104 (11): 3423.
https://doi.org/10.1182/blood.V104.11.3423.3423
Published: 2004